Dubravka Drabek

3.3k citations

35 papers · 1.8k indexed · 1 hit paper · h-index 21

Infectious Diseases top 2%
Molecular Biology top 10%
Immunology top 10%
Radiology, Nuclear Medicine and Imaging top 5%
Genetics top 10%

Co-authors: Frank Grosveld Rien van Haperen Berend‐Jan Bosch Bart L. Haagmans Nisreen M.A. Okba Frank J. M. van Kuppeveld Chunyan Wang Wentao Li
Topics: SARS-CoV-2 and COVID-19 Research (7 papers)CRISPR and Genetic Engineering (7 papers)Animal Genetics and Reproduction (7 papers)
Cited by: Infectious Diseases Animal Science and Zoology Immunology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Nature Communications
Partner nations: Netherlands United Kingdom Greece

In The Last Decade

Dubravka Drabek

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A human monoclonal antibody blocking SARS-CoV-2 infection

2020 729 citations Chunyan Wang, Wentao Li et al. Nature Communications profile →

Peers

Countries citing papers authored by Dubravka Drabek

Since Specialization

Citations

This map shows the geographic impact of Dubravka Drabek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dubravka Drabek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dubravka Drabek more than expected).

Fields of papers citing papers by Dubravka Drabek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dubravka Drabek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dubravka Drabek. The network helps show where Dubravka Drabek may publish in the future.

Co-authorship network of co-authors of Dubravka Drabek

This figure shows the co-authorship network connecting the top 25 collaborators of Dubravka Drabek. A scholar is included among the top collaborators of Dubravka Drabek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dubravka Drabek. Dubravka Drabek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neutralizing antibodies reveal cryptic vulnerabilities and interdomain crosstalk in the porcine deltacoronavirus spike protein 2024 ·Nature Communications ·Wenjuan Du,(unknown),Dubravka Drabek,Rien van Haperen,(unknown),(unknown),Ieva Drulyte,Frank J. M. van Kuppeveld,Frank Grosveld,Daniel L. Hurdiss,Berend‐Jan Bosch	5
2	High throughput identification of human monoclonal antibodies and heavy-chain-only antibodies to treat snakebite 2024 ·SHILAP Revista de lepidopterología ·Julien Slagboom,A. Lewis,(unknown),Rien van Haperen,(unknown),Mátyás A. Bittenbinder,Freek J. Vonk,Nicholas R. Casewell,Frank Grosveld,Dubravka Drabek,Jeroen Kool	3
3	Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants 2023 ·Frontiers in Immunology ·Wenjuan Du,(unknown),Anna Z. Mykytyn,Wentao Li,Dubravka Drabek,Rien van Haperen,(unknown),Melanie Rissmann,(unknown),(unknown),Itziar Serna Martin,Frank J. M. van Kuppeveld,Daniel L. Hurdiss,Bart L. Haagmans,Frank Grosveld,Berend‐Jan Bosch	1
4	Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes 2022 ·Nature Communications ·Chunyan Wang,Emma L. Hesketh,(unknown),Wentao Li,(unknown),Dubravka Drabek,Rien van Haperen,(unknown),Frank J. M. van Kuppeveld,Frank Grosveld,Neil A. Ranson,Joost Snijder,Raoul J. de Groot,Daniel L. Hurdiss,Berend‐Jan Bosch	20
5	A Transgenic Heavy Chain IgG Mouse Platform as a Source of High Affinity Fully Human Single-Domain Antibodies for Therapeutic Applications 2022 ·Methods in molecular biology ·Dubravka Drabek,(unknown),Rien van Haperen,Frank Grosveld	5
6	An anti-CTLA-4 heavy chain–only antibody with enhanced T _reg depletion shows excellent preclinical efficacy and safety profile 2022 ·Proceedings of the National Academy of Sciences ·(unknown),Qianqian Shan,He Li,(unknown),(unknown),Yun He,Fei Chen,Rien van Haperen,Dubravka Drabek,Jin Li,(unknown),(unknown),(unknown),(unknown),Victor Chen,Jingsong Wang,Yiping Rong,Frank Grosveld	33
7	A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies 2021 ·Nature Communications ·Chunyan Wang,Rien van Haperen,Francisco J. Gutierrez-Alvarez,Wentao Li,Nisreen M.A. Okba,Irina C. Albulescu,Ivy Widjaja,Brenda van Dieren,Raúl Fernández‐Delgado,Isabel Sola,Daniel L. Hurdiss,Olalekan Daramola,Frank Grosveld,Frank J. M. van Kuppeveld,Bart L. Haagmans,Luis Enjuanes,Dubravka Drabek,Berend‐Jan Bosch	95
8	A human monoclonal antibody blocking SARS-CoV-2 infectionbreakdown → 2020 ·Nature Communications ·Chunyan Wang,Wentao Li,Dubravka Drabek,Nisreen M.A. Okba,Rien van Haperen,Albert D. M. E. Osterhaus,Frank J. M. van Kuppeveld,Bart L. Haagmans,Frank Grosveld,Berend‐Jan Bosch	729
9	Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection 2018 ·Science Advances ·V. Stalin Raj,Nisreen M.A. Okba,Francisco J. Gutierrez-Alvarez,Dubravka Drabek,Brenda van Dieren,W. Widagdo,Mart M. Lamers,Ivy Widjaja,Raúl Fernández‐Delgado,Isabel Sola,Albert Bensaïd,Marion Koopmans,Joaquím Segalés,Albert D. M. E. Osterhaus,Berend‐Jan Bosch,Luis Enjuanes,Bart L. Haagmans	59
10	A Role for PML in Innate Immunity 2011 ·Genes & Cancer ·Andrea Lunardi,Mirella Gáboli,Marco Giorgio,Roberta Rivi,Anne E. Bygrave,Michael Antoniou,Dubravka Drabek,Elaine Dzierzak,Matteo Fagioli,Leonardo Salmena,Marina Botto,Carlos Cordon‐Cardo,Lucio Luzzatto,Pier Giuseppe Pelicci,Frank Grosveld,Pier Paolo Pandolfi	42
11	Generation of heavy-chain-only antibodies in mice 2006 ·Proceedings of the National Academy of Sciences ·(unknown),Sylvia Dekker,Rudi W. Hendriks,George Panayotou,Alexandra van Remoortere,(unknown),Frank Grosveld,Dubravka Drabek	60
12	Stable expression of human growth hormone over 50 generations in transgenic insect larvae 2006 ·Transgenic Research ·Maria Markaki,Dubravka Drabek,Ioannis Livadaras,R K Craig,Frank Grosveld,Charalambos Savakis	4
13	Transposition of the drosophila hydei minos transposon in the mouse germ line 2003 ·Genomics ·Dubravka Drabek,Laskaro Zagoraiou,(unknown),An Langeveld,(unknown),Clio Mamalaki,Charalambos Savakis,Frank Grosveld	39
14	The tomato RNA-directed RNA polymerase has no effect on gene silencing by RNA interference in transgenic mice 2002 ·Transgenic Research ·Ton de Wit,Frank Grosveld,Dubravka Drabek	6
15	Enforced Expression of GATA-3 During T Cell Development Inhibits Maturation of CD8 Single-Positive Cells and Induces Thymic Lymphoma in Transgenic Mice 2001 ·The Journal of Immunology ·Martijn C. Nawijn,Rita Ferreira,Gemma M. Dingjan,(unknown),Dubravka Drabek,Alar Karis,Frank Grosveld,Rudi W. Hendriks	80
16	The role of the −50 region of the human γ-globin gene in switching 2001 ·The EMBO Journal ·Maria Serafina Ristaldi,Dubravka Drabek,Joost Gribnau,(unknown),(unknown),(unknown),F. Grosveld,A. Imam	11
17	Murine MHC class II locus control region drives expression of human β-glucocerebrosidase in antigen presenting cells of transgenic mice 1999 ·Gene Therapy ·Jacky Guy,Rob Willemsen,An Langeveld,Frank Grosveld,Dubravka Drabek	1
18	Microinjection of Cre recombinase RNA induces site-specific recombination of a transgene in mouse oocytes 1998 ·Nucleic Acids Research ·Thijs de Wit,Dubravka Drabek,Frank Grosveld	26
19	The expression of bacterial nitroreductase in transgenic mice results in specific cell killing by the prodrug CB1954 1997 ·Gene Therapy ·Dubravka Drabek,Jacky Guy,R W Craig,F. Grosveld	57
20	Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy 1995 ·Molecular Biotechnology ·Jacky Guy,Dubravka Drabek,Michael Antoniou	89

About Dubravka Drabek

Dubravka Drabek is a scholar working on Genetics, Animal Science and Zoology and Infectious Diseases, having authored 35 papers that have together received 1.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), CRISPR and Genetic Engineering (7 papers) and Animal Genetics and Reproduction (7 papers). The work is most often cited by research in Infectious Diseases (927 citations), Animal Science and Zoology (158 citations) and Immunology (302 citations). Dubravka Drabek has collaborated with scholars based in Netherlands, United Kingdom and Greece. Frequent co-authors include Frank Grosveld, Rien van Haperen, Berend‐Jan Bosch, Bart L. Haagmans, Nisreen M.A. Okba, Frank J. M. van Kuppeveld, Chunyan Wang, Wentao Li, Albert D. M. E. Osterhaus and Jacky Guy. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact